Induced pluripotency and oncogenic transformation are related processes.
about
Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and ChallengesImmunogenicity and tumorigenicity of pluripotent stem cells and their derivatives: genetic and epigenetic perspectivesCell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directionsMetabolic control of cancer cell stemness: Lessons from iPS cellsChallenges in identifying the best source of stem cells for cardiac regeneration therapyInduced pluripotent stem cells show metabolomic differences to embryonic stem cells in polyunsaturated phosphatidylcholines and primary metabolismIdentification of DPPA4 and DPPA2 as a novel family of pluripotency-related oncogenes.Somatic polyploidy is associated with the upregulation of c-MYC interacting genes and EMT-like signatureThe Dual Roles of MYC in Genomic Instability and Cancer ChemoresistanceA human pluripotent stem cell surface N-glycoproteome resource reveals markers, extracellular epitopes, and drug targets.The nutritional phenome of EMT-induced cancer stem-like cellsp53: the barrier to cancer stem cell formation.The Activation of the Sox2 RR2 Pluripotency Transcriptional Reporter in Human Breast Cancer Cell Lines is Dynamic and Labels Cells with Higher Tumorigenic Potential.Deregulated proliferation and differentiation in brain tumors.Scientists: you really need to get out of the lab more"Second-generation" stem cells for cardiac repairImmunoreactivity of Pluripotent Markers SSEA-5 and L1CAM in Human Tumors, Teratomas, and Induced Pluripotent Stem CellsMesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fearsA Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In VitroStalling the engine of resistance: targeting cancer metabolism to overcome therapeutic resistance.Analysis of induced pluripotent stem cells from a BRCA1 mutant family.Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.The mitochondrial H(+)-ATP synthase and the lipogenic switch: new core components of metabolic reprogramming in induced pluripotent stem (iPS) cells.Epigenetic memory in the context of nuclear reprogramming and cancer.Current tissue engineering strategies in anterior cruciate ligament reconstruction.In vivo reprogramming in inflammatory bowel disease.Histone H3.3 mutations: a variant path to cancer.Epigenetic mechanisms of tumorigenicity manifesting in stem cells.Behavior of Xeno-Transplanted Undifferentiated Human Induced Pluripotent Stem Cells Is Impacted by Microenvironment Without Evidence of Tumors.Transplantation of human villous trophoblasts preserves cardiac function in mice with acute myocardial infarction.Modeling the autistic cell: iPSCs recapitulate developmental principles of syndromic and nonsyndromic ASD.Stem cells and diabetic cardiomyopathy: from pathology to therapy.Stem Cell Therapy: A New Therapeutic Option for Cardiovascular Diseases.PRG3 induces Ras-dependent oncogenic cooperation in gliomas.The Warburg effect version 2.0: metabolic reprogramming of cancer stem cells.Linking Pluripotency Reprogramming and CancerERBB3-Binding Protein 1 (EBP1) Is a Novel Developmental Pluripotency-Associated-4 (DPPA4) Cofactor in Human Pluripotent Cells.While it is not deliberate, much of today's biomedical research contains logical and technical flaws, showing a need for corrective action.Stem cell therapy targeting the right ventricle in pulmonary arterial hypertension: is it a potential avenue of therapy?
P2860
Q26775061-4B7A8E0B-3712-4D88-A092-028D5CDABC09Q26849530-0AF3BBBB-6A16-42EF-9A7E-6ECA3B4A365AQ27001159-C91A768C-6926-441E-A1F9-F94F09E70A13Q28081608-97787EA4-3652-406E-A3A4-3BD1CA081CC3Q28083859-531492C2-63E7-4DE8-B280-CFE82B764863Q28484399-2A9D8A3C-AC38-438C-A3D6-573D5B2A7CB5Q30662635-82A4C08F-8163-426E-8C93-226F219DAE71Q33363918-E9D3C7E9-8C36-41F9-8460-AF3F5334BDA1Q33836799-CADD944C-F40E-43D9-90C4-09E0FF8D2899Q33949177-403AE385-7BEC-4FEE-8403-2E40DCC0B802Q34100815-43CAF5E4-0DD1-4F87-9BFD-A720A8D34F9CQ34406072-FF38761E-7DF7-4EB3-B4B9-E4DAB978665DQ34452128-44359DBB-E12A-40D9-B66B-FC8914B9899EQ34859989-7A58555F-1048-4CCD-AAB3-B9BCBB484DE2Q35128468-7EB17888-427F-407D-9B5C-DE6BFE7004E4Q35205665-98DC0902-EB22-4A01-AD5E-BB6DBF5BCEF4Q35623479-61F7A5AD-1FAD-48CE-9BE9-9A0B538F684FQ35774310-425E2297-CD81-4D2C-8FFF-C67BADD6CFB6Q36394208-F2A9D4AE-37D5-489B-B4A0-66AF1310C4A8Q36815271-359E9CEF-8651-47E0-AAA3-A126594D4C78Q37360925-560F485C-ACB7-4371-9DA4-5F3A9A772D07Q37420064-71E572BB-A64B-43E4-B55A-48B655CF5920Q38071479-BDC9D36E-1182-4434-9E48-AEBD95C2F1BBQ38098977-02E0E633-F48F-426F-BB11-A539BA065D20Q38112051-000A7133-952B-4A5E-8D2F-EE416BA65FF9Q38136473-55A779BB-FECF-4F74-A5E5-839BBCD85311Q38162525-4C77C989-1B53-42A2-8B62-8A3AE972F1ADQ38220397-4AF13413-57CF-4CED-85AA-5411103C3CAFQ38685965-74E6DEA6-1638-44C9-9367-BF97350872F7Q38775197-C1B439B6-6B83-4066-97AF-BFB7C2B58ECFQ38816786-EC09CE18-6B03-400B-B0A6-BCC514221E0BQ38843402-45FC4793-A521-4CD6-9D9F-CD322E6B8124Q39329517-6F986AA9-8AD3-4AFA-A27D-4805D60001C9Q41225581-3A61C40C-E0CE-47D0-BCC3-180ACC28B390Q41831013-F22814E0-E9D2-4074-B2D2-5291D24E9FDFQ42247704-74FAAB56-CCA2-456E-844D-DEC4B28D8D66Q48255288-E51158F1-2B2F-46AE-8447-FF05C193BE07Q52671014-BAC70442-8A6F-44D0-9DFE-3467C3A38D89Q52685704-A4CC8771-ECEA-4293-A04E-B5C69D80DFD0
P2860
Induced pluripotency and oncogenic transformation are related processes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Induced pluripotency and oncogenic transformation are related processes.
@en
type
label
Induced pluripotency and oncogenic transformation are related processes.
@en
prefLabel
Induced pluripotency and oncogenic transformation are related processes.
@en
P2093
P2860
P356
P1476
Induced pluripotency and oncogenic transformation are related processes.
@en
P2093
Bonnie L Barrilleaux
John W Riggs
Kelly M Bush
Natasha Varlakhanova
Paul S Knoepfler
Vanessa Chan
P2860
P356
10.1089/SCD.2012.0375
P577
2012-10-26T00:00:00Z